Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Circ Cardiovasc Interv. 2016 Jun;9(6):10.1161/CIRCINTERVENTIONS.115.003434 e003434. doi: 10.1161/CIRCINTERVENTIONS.115.003434

Table 4.

Largest Published CTO PCI Series to Date Including >200 Retrograde PCIs.

Study Year Retrograde PCI n,
(%)		 Primary
retrograde*
(%)		 Prior failed CTO
PCI in retrograde
group (%)		 Overall technical
success in
retrograde group† (%)		 MACE in
retrograde
group† (%)
Kimura et al.22 2009 224 100 65 92 1.8
Galassi et al.23 2011 234 (12) 76 U 65 3.0
Karmpaliotis et al.12 2012 462 (34) 46 18 81 2.6
Yamane et al.24 2013 378 (25) 75 32 84 0.5
Tsutchikane et al.25 2013 801 (27) 67 29 85 1.6
Galassi et al.7 2015 1582 (16) 76 43 75 0.8
Present Study 2015 539 (41) 46 21 85 4.3
*

Retrograde as first crossing strategy during index procedure.

†

Definition varies according to study.

CTO, chronic total occlusion; MACE, major adverse cardiovascular events; PCI, percutaneous coronary intervention; U, unknown